Two year follow-up of atypical depression

Journal of Psychiatric Research

Volumn 33, Issue 1, 1999, Pages 23-29

  Zubieta, Jon Kar ^a   Pande, Atul C ^a   Demitrack, Mark A ^a  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

Antidepressants; Atypical depression; Course; Depressive disorders; Outcome; Recurrence

Indexed keywords

ANTIDEPRESSANT AGENT; FLUOXETINE; PHENELZINE;

ADULT; ARTICLE; CLINICAL ARTICLE; DEPRESSION; FEMALE; FOLLOW UP; HUMAN; HYPOMANIA; INTERVIEW; MALE; PRIORITY JOURNAL; RECURRENT DISEASE; SOCIAL INTERACTION;

EID: 0032894573     PISSN: 00223956     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-3956(98)00035-1     Document Type: Article

References (33)

1. Akiskal HS. The bipolar spectrum: New concepts in classification and diagnosis. In: Grinspoon L, editor. Psychiatry Update. Washington D.C.: American Psychiatric Press 1983. p. 271-92.
2. Angst J, Merikangas K. The depressive spectrum: diagnostic classification and course. Journal of Affective Disorders 1997;45:31-40.
3. Asnis GM, McGinn LK, Sanderson WC. Atypical depression: clinical aspects and noradrendergic function. American Journal of Psychiatry 1995;152:31-6.
4. Bronisch T, Wittchen HU, Krieg C, Rupp HU, von Zerssen D. Depressive neurosis. A long-term prospective and retrospective follow-up study of former inpatients. Acta Psychiatrica Scandinavica 1985;71:237-48.
5. Bruder GE, Towey JP, Stewart JW, Friedman D, Tenke C, Quitkin FM. Event-related potentials in depression: influence of task, stimulus hemifield and clinical features on P3 latency. Biological Psychiatry 1991;30:233-46.
6. Ceroni GB, Nevi C, Pezzoli A. Chronicity in major depression. Journal of Affective Disorders 1984;7:123-32.
7. Dew MA, Reynolds CF, Houck PR, Hall M, Buysse DJ, Frank E, Kupfer DJ. Temporal profiles of the course of depression during treatment. Predictors of outcome toward recovery in the elderly. Archives of General Psychiatry 1997;54:1016-24.
8. Eaton WW, Anthony JC, Gallo J, Cai G, Tien A, Romanoski A, Lyketsos C, Chen L-S. Natural history of diagnostic interview schedule/DSM-IV major depression. Archives of General Psychiatry 1997;54:993-9.
9. Ebert D, Barocka A. The early course of atypical depression. European Archives of Psychiatry and Clinical Neurosciences 1991;241:131-2.
10. Greenhouse JB, Kupfer DJ, Frank E, Jarrett DB, Rejman KA. Analysis of time to stabilization in the treatment of depression. Journal of Affective Disorders 1987;13:259-66.
11. Keller MB, Klerman GL, Lavori PW, Coryell W, Endicott J, Taylor J. Long term outcomes in major depression. JAMA 1984;252:788-9.
12. Keller MB, Lavori PW, Friedman BL, Nielson E, McDonald-Scott P, Andreasen NC, Endicott J. The LIFE II: a comprehensive method for assessing outcome in prospective longitudinal studies. Archives of General Psychiatry 1987;44:540-9.
13. Keller MB, Shapiro RW. Major depressive disorder: initial results from a one year prospective naturalistic follow-up. Journal of Nervous and Mental Disorders 1981;169:761-8.
14. Keller MB, Shapiro RW, Lavori PW, Wolfe N. Recovery in major depressive disorder: analysis with the life table. Archives of General Psychiatry 1982a;39:905-10.
15. Keller MB, Shapiro RW, Lavori PW, Wolfe N. Relapse in major depression: analysis with the life table. Archives of General Psychiatry 1982b;39:911-5.
16. Lee AS, Murray RM. The long-term outcome of Maudsley depressives. British Journal of Psychiatry 1988;153:741-51.
17. Lehmann HE, Fenton FR, Deutsch M, Feldman S, Engelsmann F. An 11-year follow-up study of 110 depressed patients. Acta Psychiatrica Scandinavica 1988;78:57-65.
18. Liebowitz MR, Quitkin FM, Stewart JW, McGrath PJ, Harrison WM, Markowitz JS, Rabkin JG, Tricamo E, Goetz DM, Klein DF. Antidepressant specificity in atypical depression. Archives of General Psychiatry 1988;45:129-37.
19. McGlashan T. The Documentation of Clinical Psychotropic Drug Trials. National Institute of Mental Health, Rockville, MD 1973.
20. Nierenberg AA, Pava JA, Clancy K, Rosenbaum JF, Fava M. Are neurovegetative symptoms stable in relaing or recurrent atypical depressive episodes? Biological Psychiatry 1996;40:691-6.
21. Pande AC, Birkett M, Fechner-Bates S, Haskett RF, Greden JF. Fluoxetine versus phenelzine in atypical depression. Biological Psychiatry 1996;40:1017-20.
22. Quitkin FM, Harrison W, Liebowitz M, McGrath P, Rabkin JG, Stewart J, Markowitz J. Defining the boundaries of atypical depression. Journal of Clinical Psychiatry 1984;45:19-21.
23. Quitkin FM, McGrath PJ, Stewart JW, Harrison W, Wager SG, Nunes E, Rabkin JG, Tricamo E, Markowitz J, Klein DF. Phenelzine and imipramine in mood reactive depressives. Further delineation of the syndrome of atypical depression. Archives of General Psychiatry 1989;46:787-93.
24. Quitkin FM, Rabkin JG, Stewart JW, McGrath PJ, Harrison W, Davies M, Goetz R, Puig-Antich J. Sleep of atypical depressives. Journal of Affective Disorders 1985;8:61-7.
25. Quitkin FM, Stewart JW, McGrath PJ, Liebowitz MR, Harrison WM, Tricamo E, Klein DF, Rabkin JG, Markowitz JS, Wager SG. Phenelzine versus imipramine in the treatment of probable atypical depression: defining syndrome boundaries of selective MAOI responders. American Journal of Psychiatry 1988;145:306-11.
26. Sargeant JK, Bruce ML, Florio LP, Weissman MM. Factors associated with 1-year outcome of major depression in the community. Archives of General Psychiatry 1990;47:519-26.
27. Shea MT, Elkin I, Imber SD, Sotsky SM, Watkins JT, Collins JF, Pilkonis PA, Beckham E, Glass DR, Dolan R. Course of depressive symptoms over follow-up. Findings from the National Institute of Mental Health Treatment of Depression Collaborative Research Program. Archives of General Psychiatry 1992;49:782-7.
28. Solomon DA, Keller MB, Leon AC, Mueller TI, Shea MT, Warshaw M, Maser JD, Coryel W, Endicott J. Recovery from major depression. A 10-year prospective follow-up across multiple episodes. Archives of General Psychiatry 1997;54:1001-6.
29. Spitzer RL, Endicott J. Schedule for Affective Disorders and Schizophrenia. Biometrics Research, New York Psychiatric Institute, New York 1975.
30. Spitzer RL, Williams JBW, Gibbon M, First BM. Structured Clinical Interview for DSM-III-R-Patient edition. Biometrics Research Department, New York Psychiatric Institute, New York 1989.
31. Stewart JW, Tricamo E, McGrath PJ, Quitkin FM. Prophylactic efficacy of phenelzine and imipramine in chronic atypical depression: likelihood of recurrence on discontinuation after 6 months' remission. American Journal of Psychiatry 1997;154:31-6.
32. Stewart JW, McGrath PJ, Quitkin FM, Harrison W, Markowitz J, Wager S, Leibowitz MR. Relevance of DMS-III depressive subtype and chronicity of antidepressant efficacy in atypical depression. Differential response to phenelzine, imipramine, and placebo. Archives of General Psychiatry 1989;46:1080-7.
33. Wells KB, Burnam MA, Rogers W, Hays R, Camp P. The course of depression in adult outpatients. Results from the Medical Outcomes Study. Archives of General Psychiatry 1992;49:788-94.